108P Copy loss enrichment at metastatic disease progression in hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer patients treated with endocrine therapy and CDK4/6 inhibition

Autor:	A.A. Davis, J. Luo, T. Zheng, C. Dai, R. Suresh, F.O. Ademuyiwa, C. Rigden, K. Clifton, K. Weilbaecher, A.E. Frith, P. Tandra, T. Summa, S. Thomas, L. Peterson, X. Wang, P. Du, S. Jia, B.L. King, J. Krishnamurthy, C.X. Ma
Rok vydání:	2022
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 33:S587-S588
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::122374b599b9310d98ce180dd902e23a https://doi.org/10.1016/j.annonc.2022.07.140 Zobrazit plný text záznamu